View Author
dai: 264424689
scopus: 6506071197

Nijhuis, R.L.

(Rogier Nijhuis)


disease model study rotterdam function event population stroke pressure heart subject factor blood index individual aspirin framingham systolic blood pressure score risk factors mortality infarction aspirin therapy risc model therapy prevention value table heart disease indicator risk indicators ankle-arm index patient cholesterol ratio level rotterdam study probability chapter strategy baseline health atherosclerosi follow-up risk function transition probability functions analysis effect systolic simulation history prediction cost-effectiveness state smoking ischemic polypill progression cohort death ankle-arm rotterdam study population result life expectancy benefit hazard blood pressure haplotype women expectancy transition diastolic blood pressure cvd mortality measurement estrogen disease risk function medication measure angina pectoris group




3 Most Recent Publications

Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. (Article)
Schuit, S.C.E. Oei, H.H. Pols, H.A.P. Uitterlinden, A.G. Witteman, J.C.M. Geurts van Kessel, C.H. Meurs, J.B.J. van Nijhuis, R.L. Leeuwen, J.P.T.M. van Jong, F.H. de Zillikens, M.C. Hofman, A.
2004-06-23
Cardiovascular Disease Prevention Strategies (Doctoral Thesis)
Nijhuis, R.L.
2004-06-09
C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study (Article)
Maat, M.P.M. de Hak, A.E. Kiliaan, A.J. Sol, A.I. del Kuip, D.A. van der Nijhuis, R.L. Witteman, J.C.M. Hofman, A.
2002-01-01